Watchlist Price Alert

Liminatus Pharma Inc. War... (LIMNW)

NASDAQ: LIMNW · Real-Time Price · USD

0.09

-0.01 (-10.00%)

At close: May 27, 2025, 1:31 PM

Liminatus Pharma Warrants Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2024	Q4 2023	Q1 2023
Period Ending	Mar 31, 2024	Dec 31, 2023	Mar 31, 2023
Net Income	-772.31M	85.92M	-648.72M
Depreciation & Amortization	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a
Other Working Capital	-109.39M	161.6M	-342.55M
Other Non-Cash Items	1.38B	1.25B	24.94M
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	-780.09M	-603.97M	-103.79M
Operating Cash Flow	-172.55M	731.17M	-727.57M
Capital Expenditures	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a
Other Investing Acitivies	-10.5B	-10.74B	688.55M
Investing Cash Flow	-10.5B	-10.74B	688.55M
Debt Repayment	64.55M	-635.45M	108.72M
Common Stock Repurchased	10.35B	10.35B	-305.01M
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a
Financial Cash Flow	10.42B	9.72B	-196.29M
Net Cash Flow	-527.48M	-572.59M	-235.3M
Free Cash Flow	-172.55M	731.17M	-727.57M